Tag Archive for: Calluna

M&A

Innate immunity merger raises €75m

Forbion has spearheaded a €75m Series A financing in Norwegian biotech Calluna Pharma. The clinical-stage company resulted from the merger of Oxitope Pharma and Arxx Therapeutics.

Read more